Cargando…
Melatonin Regulates Cisplatin Resistance and Glucose Metabolism Through Hippo Signaling in Hepatocellular Carcinoma Cells
INTRODUCTION AND AIM: Hepatocellular carcinoma (HCC) is a primary malignancy that occurs in the liver. Clinical cases have been recorded worldwide, particularly in the Saharan area and Asia. In the present work, we aimed to probe the characteristics of melatonin involved in human HCC development, es...
Autores principales: | Mi, Lina, Kuang, Hongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075351/ https://www.ncbi.nlm.nih.gov/pubmed/32210629 http://dx.doi.org/10.2147/CMAR.S230466 |
Ejemplares similares
-
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
por: Liu, Yuchen, et al.
Publicado: (2020) -
KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling
por: Tong, Rongliang, et al.
Publicado: (2017) -
MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
por: Zhou, Xin, et al.
Publicado: (2022) -
Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma
por: Yang, So Mi, et al.
Publicado: (2023) -
Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
por: Lo Sardo, Federica, et al.
Publicado: (2017)